In a 61‑year‑old woman with mild leukopenia (white blood cell count 3.8 K/µL) due to neutropenia (absolute neutrophil count 1.3 ×10^3/µL) and relative lymphocytosis, and a mild normocytic‑normochromic anemia (hemoglobin 11.1 g/dL, hematocrit 35.9 %), what is the appropriate interpretation and recommended diagnostic work‑up?

Laboratory Interpretation and Diagnostic Work-Up

This 61-year-old woman has mild neutropenia (ANC 1.3 ×10³/µL) with normocytic anemia requiring a focused evaluation to exclude secondary causes, medication effects, ethnic variation, and early clonal hematopoiesis before attributing findings to age-related changes.

Key Laboratory Abnormalities

The complete blood count reveals three distinct abnormalities requiring interpretation:

• Mild leukopenia (WBC 3.8 K/µL) driven primarily by neutropenia
• Absolute neutropenia (ANC 1.3 ×10³/µL) - below the 2.0 threshold but above severe neutropenia (<0.5)
• Mild normocytic anemia (Hgb 11.1 g/dL, MCV 83.3 fL, MCHC 31.0 g/dL)
• Relative lymphocytosis (46%) and mild monocytosis (14.6%) as compensatory changes
• Elevated RDW (16.0%) suggesting heterogeneous red cell population

Immediate Diagnostic Priorities

1. Establish Chronicity and Exclude Acute Causes

Repeat CBC with differential in 2-4 weeks to determine if neutropenia is persistent (>3 months defines chronic neutropenia) 1, 2. A single measurement cannot distinguish transient from chronic neutropenia.

2. Critical History Elements

Obtain specific information about:

• Ethnicity: African descent or Middle Eastern ancestry (25-50% have benign ethnic neutropenia with ANC as low as 1.0 ×10³/µL without increased infection risk) 3, 4
• Medication exposure: Particularly tamoxifen, chemotherapy, immunosuppressants, antibiotics, anticonvulsants 5
• Infection history: Recurrent bacterial/fungal infections suggest functional neutropenia 1
• Cyclic symptoms: Fever, mouth ulcers every 21 days suggests cyclic neutropenia 2
• Autoimmune conditions: Rheumatoid arthritis, lupus, Sjögren's syndrome
• Family history: Congenital neutropenia patterns 1

3. Anemia Evaluation

The normocytic anemia requires parallel investigation 6:

• Iron studies: Serum ferritin and transferrin saturation (iron deficiency in postmenopausal women warrants GI bleeding evaluation)
• Vitamin B12 and folate levels
• Reticulocyte count: Assess bone marrow response appropriateness
• Renal function: Creatinine and eGFR (anemia of CKD is normocytic-normochromic and indistinguishable from chronic disease) 6
• Inflammatory markers: CRP, ESR

Risk Stratification for Bone Marrow Examination

Indications for Early Bone Marrow Biopsy

Proceed directly to bone marrow examination if:

• Neutropenia persists beyond 3 months without clear secondary cause 1
• Any additional cytopenia develops (bicytopenia or pancytopenia warrants hematology consultation) 6
• Unexplained splenomegaly or constitutional symptoms 7
• Progressive decline in counts on serial monitoring
• Poor response to empiric interventions

Critical pitfall: Isolated neutropenia in elderly patients can herald high-risk clonal evolution including AML-MRC with TP53 mutations, which may present without other cytopenias initially 7. The "watch-and-wait" approach risks missing early intervention windows.

Bone Marrow Studies Should Include:

• Morphology with differential count
• Cytogenetics (conventional karyotype)
• Flow cytometry if lymphoproliferative disorder suspected
• Consider FISH for del(20q), i(17q), TP53 if dysplasia present 7

Algorithmic Approach

Step 1: Repeat CBC in 2-4 weeks

• If normalized → likely transient/reactive
• If persistent → proceed to Step 2

Step 2: Exclude secondary causes

• Review medications (stop potential offenders)
• Check B12, folate, iron studies, renal function, TSH
• Assess ethnic background (consider Duffy antigen testing if African/Middle Eastern descent) 4
• Viral serologies if clinically indicated (HIV, hepatitis, EBV, CMV)

Step 3: If neutropenia persists >3 months without identified cause

• Bone marrow examination with cytogenetics 1
• Neutrophil antibody testing (only interpret with bone marrow context) 1
• Consider genetic testing for congenital neutropenia if family history or young age at presentation

Step 4: Classify chronic neutropenia type

• Autoimmune neutropenia (positive antibodies, associated conditions)
• Cyclic neutropenia (21-day cycles)
• Chronic idiopathic neutropenia
• T-cell large granular lymphocyte leukemia 2
• Early myelodysplastic syndrome 7

Management Considerations

Current ANC 1.3 ×10³/µL (Mild Neutropenia)

• No prophylactic G-CSF indicated at this level 2
• No prophylactic antibiotics unless severe (<0.5) or recurrent infections 2
• Educate on infection precautions and early treatment-seeking
• Monitor for fever, oral ulcers, skin infections

If Severe Neutropenia Develops (ANC <0.5)

• G-CSF becomes first-line therapy 1, 8
• Aggressive treatment of bacterial/fungal infections 1
• Long-term G-CSF carries MDS/AML risk in congenital forms, requiring surveillance 1

Prognosis by Etiology

• Benign ethnic neutropenia: No increased infection risk, no treatment needed 3
• Autoimmune, cyclic, idiopathic: Virtually no MDS/AML risk 1
• Severe congenital neutropenia: Significant MDS/AML evolution risk, especially with poor G-CSF response 1

The combination of neutropenia with normocytic anemia in a 61-year-old woman mandates exclusion of early myelodysplasia, particularly given recent evidence that isolated neutropenia can be the sentinel finding of high-risk clonal evolution 7.